Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Cyclacel Pharmaceuti

(NASDAQ: CYCC)
Add to Portfolio
+0.62 (+30.69%)
as of May 31, 2024

Values in US Thousands
  12-2023 12-2022 12-2021 12-2020
Sales $ 420 - - -
Gross Profit 420 - - -
Operating Expenses 25,873 27,656 22,389 10,636
Operating Income -25,453 -27,656 -22,389 -10,636
Other Income/Expenses -98 1,741 204 955
Pre-tax Income -25,551 -25,915 -22,185 -9,681
Income Taxes -2,996 -4,717 -3,728 -1,236
Net Income from Cont. Operations -22,555 -21,198 -18,457 -8,445
Total Net Income $ -22,555 $ -21,198 $ -18,457 $ -8,445
Basic EPS from Cont. Ops. -26.51 -32.23 -31.00 -34.85
Basic EPS from Total Ops. -26.75 -28.70 -31.33 -51.27
Diluted EPS from Cont. Ops -26.51 -32.23 -31.00 -34.85
Diluted EPS from Total Operations -26.75 -28.70 -31.33 -51.27
EBITDA -25,422 -27,624 -22,346 -10,616